BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 34861605)

  • 1. Predicting optimal use of continuous glucose monitors in adolescents with type 1 diabetes: It's about benefit and burden.
    Messer LH; Cook PF; Lowe NK; Hood KK; Driscoll KA; Hernandez TL
    J Pediatr Nurs; 2022; 62():23-29. PubMed ID: 34861605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CGM Benefits and Burdens: Two Brief Measures of Continuous Glucose Monitoring.
    Messer LH; Cook PF; Tanenbaum ML; Hanes S; Driscoll KA; Hood KK
    J Diabetes Sci Technol; 2019 Nov; 13(6):1135-1141. PubMed ID: 30854886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Continuous Glucose Monitoring Uptake in Underserved Youth with Type 1 Diabetes: The IMPACT Study.
    Lin T; Manfredo JA; Illesca N; Abiola K; Hwang N; Salsberg S; Akhtar Y; Mathioudakis N; Brown EA; Wolf RM
    Diabetes Technol Ther; 2023 Jan; 25(1):13-19. PubMed ID: 36223197
    [No Abstract]   [Full Text] [Related]  

  • 4. Perceived Burdens and Benefits Associated With Continuous Glucose Monitor Use in Type 1 Diabetes Across the Lifespan.
    Divan V; Greenfield M; Morley CP; Weinstock RS
    J Diabetes Sci Technol; 2022 Jan; 16(1):88-96. PubMed ID: 33356514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous Glucose Monitoring (CGM) Adherence in Youth With Type 1 Diabetes: Associations With Biomedical and Psychosocial Variables.
    Giani E; Snelgrove R; Volkening LK; Laffel LM
    J Diabetes Sci Technol; 2017 May; 11(3):476-483. PubMed ID: 27807014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapy.
    Olivier P; Lawson ML; Huot C; Richardson C; Nakhla M; Romain J
    J Diabetes Sci Technol; 2014 May; 8(3):523-8. PubMed ID: 24876616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous Glucose Monitoring in Adolescents With Obesity: Monitoring of Glucose Profiles, Glycemic Excursions, and Adherence to Time Restricted Eating Programs.
    Naguib MN; Hegedus E; Raymond JK; Goran MI; Salvy SJ; Wee CP; Durazo-Arvizu R; Moss L; Vidmar AP
    Front Endocrinol (Lausanne); 2022; 13():841838. PubMed ID: 35282464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative.
    DeSalvo DJ; Miller KM; Hermann JM; Maahs DM; Hofer SE; Clements MA; Lilienthal E; Sherr JL; Tauschmann M; Holl RW;
    Pediatr Diabetes; 2018 Nov; 19(7):1271-1275. PubMed ID: 29923262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost, Hassle, and On-Body Experience: Barriers to Diabetes Device Use in Adolescents and Potential Intervention Targets.
    Messer LH; Tanenbaum ML; Cook PF; Wong JJ; Hanes SJ; Driscoll KA; Hood KK
    Diabetes Technol Ther; 2020 Oct; 22(10):760-767. PubMed ID: 32163719
    [No Abstract]   [Full Text] [Related]  

  • 11. Pediatric Medicaid Patients With Type 1 Diabetes Benefit From Continuous Glucose Monitor Technology.
    Ravi SJ; Coakley A; Vigers T; Pyle L; Forlenza GP; Alonso T
    J Diabetes Sci Technol; 2021 May; 15(3):630-635. PubMed ID: 32172603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances, Challenges, and Cost Associated with Continuous Glucose Monitor Use in Adolescents and Young Adults with Type 1 Diabetes.
    Datye KA; Tilden DR; Parmar AM; Goethals ER; Jaser SS
    Curr Diab Rep; 2021 May; 21(7):22. PubMed ID: 33991264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis.
    Wojciechowski P; Ryś P; Lipowska A; Gawęska M; Małecki MT
    Pol Arch Med Wewn; 2011 Oct; 121(10):333-43. PubMed ID: 22045094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.
    ; Weinzimer S; Xing D; Tansey M; Fiallo-Scharer R; Mauras N; Wysocki T; Beck R; Tamborlane W; Ruedy K
    Pediatr Diabetes; 2009 Apr; 10(2):91-6. PubMed ID: 19175899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring Parental Experiences of Using a Do-It-Yourself Solution for Continuous Glucose Monitoring Among Children and Adolescents With Type 1 Diabetes: A Qualitative Study.
    Elbalshy M; Boucher S; Crocket H; Galland B; MacKenzie C; de Bock MI; Jefferies C; Wiltshire E; Wheeler BJ
    J Diabetes Sci Technol; 2020 Sep; 14(5):844-853. PubMed ID: 31875411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of Continuous Glucose Monitoring for Adults With Type 1 Diabetes Compared With Self-Monitoring of Blood Glucose: The DIAMOND Randomized Trial.
    Wan W; Skandari MR; Minc A; Nathan AG; Winn A; Zarei P; O'Grady M; Huang ES
    Diabetes Care; 2018 Jun; 41(6):1227-1234. PubMed ID: 29650803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for Therapy.
    Majithia AR; Wiltschko AB; Zheng H; Walford GA; Nathan DM
    J Diabetes Sci Technol; 2018 Jan; 12(1):76-82. PubMed ID: 28868899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Youth Involvement in the Decision to Start CGM Predicts Subsequent CGM Use.
    Miller VA; Xiao R; Slick N; Feudtner C; Willi SM
    Diabetes Care; 2020 Oct; 43(10):2355-2361. PubMed ID: 32703764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Continuous Glucose Monitoring in Youth-Onset Type 2 Diabetes.
    Chan CL
    Curr Diab Rep; 2017 Sep; 17(9):66. PubMed ID: 28726154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.